Proceedings of the 4th International Workshop of the Adrenoleukodystrophy International Research Group (ALD-IRG), University of York, 3 September 1998.
Alger
S
S
Department of Clinical Chemistry, Birmingham Children's Hospital, UK.
Green
A
A
Köhler
W
W
Sokolowski
P
P
Moser
H
H
D000326:Adrenoleukodystrophy / Q000178:diet therapy / Q000188:drug therapy* / Q000235:genetics; D000328:Adult; D002648:Child; D002985:Clinical Protocols; D004338:Drug Combinations; D004739:England; D004883:Erucic Acids / Q000009:adverse effects / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008148:Lovastatin / Q000627:therapeutic use; D008297:Male; D011446:Prospective Studies; D012189:Retrospective Studies; D014304:Triolein / Q000009:adverse effects / Q000627:therapeutic use
D004338:Drug Combinations; D004883:Erucic Acids; D000960:Hypolipidemic Agents; C079420:Lorenzo's oil; D014304:Triolein; D008148:Lovastatin